Pipelines & Software

Ask For Help

Publications

03/22/2023 - B cell-intrinsic STAT3-mediated support of latency and interferon suppression during murine gammaherpesvirus 68 infection revealed through an in vivo competition model
03/01/2023 - Follicle Center Lymphoma (FCL) of the lower female genital tract (LFGT): a novel variant of Primary Cutaneous Follicle Center Lymphoma (PCFCL)
02/07/2023 - A virus-induced circular RNA maintains latent infection of Kaposi's sarcoma herpesvirus
02/01/2023 - Oral microbiome and risk of incident head and neck cancer: a nested case-control study
01/06/2023 - Epithelial-intrinsic defects in TGF?R signaling drive local allergic inflammation manifesting as eosinophilic esophagitis
01/01/2023 - A stem cell epigenome is associated with primary nonresponse to CD19 CAR T-cells in pediatric acute lymphoblastic leukemia
11/01/2022 - Loss of Brca1 and Trp53 in adult mouse mammary ductal epithelium results in development of hormone receptor-positive or hormone receptor-negative tumors, depending on inactivation of Rb family proteins
10/28/2022 - RAS oncogene signal strength regulates matrisomal gene expression and tumorigenicity of mouse keratinocytes
09/27/2022 - Immunogenetics associated with severe coccidioidomycosis
06/27/2022 - Inhibition of HSP 90 is associated with potent anti-tumor activity in Papillary Renal Cell Carcinoma
06/21/2022 - Host CLIC4 expression in the tumor microenvironment is essential for breast cancer metastatic competence
05/18/2022 - Antisense transcription from lentiviral gene targeting linked to an integrated stress response in colorectal cancer cells
05/09/2022 - A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers
04/12/2022 - Triple combination of BET plus PI3K and NF-?B inhibitors exhibit synergistic activity in adult T-cell leukemia/lymphoma
03/01/2022 - A phase 2 study of Pembrolizumab in combination with Capecitabine and Oxaliplatin with molecular profiling in advanced biliary tract carcinoma
03/01/2022 - Remodeling the tumor microenvironment via blockade of LAIR-1 and TGF-? signaling enables PD-L1-mediated tumor eradication